Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer

Depression Clinical Trial

Official title: Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer

Status Completed

Clinical Trial Summary

esketamine is an optical isomer of ketamine. Compared with ketamine, esketamine has the characteristics of higher effective value, stronger receptor affinity, less adverse reactions of nervous system, and pharmacokinetics is controllable.

Domestic and foreign studies have focused on the therapeutic effect of esketamine on major depression, but less attention has been paid to perioperative depression.This study intends to explore the effect of small doses of esketamine on patients with breast cancer.Postoperative depression and pain are observed.

Clinical Trial Description

This study intends to explore the effect of small doses of esketamine on patients with breast cancer.WE pay attention to :

1. Safety of low-dose single intravenous injection of esketamine (1)The influence of intraoperative vital signs of patients after medication, such as blood pressure and heart rate fluctuation; (2)the duration of recovery after anesthesia; (3)postoperative adverse reactions, such as nausea and vomiting, dizziness and diplopia, respiratory depression, laryngeal spasm, delirium agitation, etc

2. Effect of single intravenous injection of low-dose ketamine on postoperative depression in patients undergoing radical mastectomy (1) 1 day before surgery, 2 days, 5 days, 30 days, 90 days after surgery Hamilton Depression Scale scores; (2) The serum leptin level 1 day before surgery, 2 days after surgery and 5 days after surgery; (3) Correlation between depression scale score and leptin level

3. Effects of low dose esketamine on acute and chronic pain in patients undergoing radical mastectomy

• visual analogue scale scores at 6, 12 and 24 hours after surgery;

• visual analogue scale scores at 3, 5, 30 and 90 days after surgery;

• the number of analgesic remedies ;

Related Conditions & MeSH terms

• Depression
• Depressive Disorder

• NCT number: NCT04850937
• Study type: Interventional
• Source: Yangzhou University
• Status: Completed
• Phase: N/A
• Start date: February 10, 2021
• Completion date: May 10, 2022